0001193125-21-091389.txt : 20210323 0001193125-21-091389.hdr.sgml : 20210323 20210323172632 ACCESSION NUMBER: 0001193125-21-091389 CONFORMED SUBMISSION TYPE: FWP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20210323 DATE AS OF CHANGE: 20210323 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Genpact LTD CENTRAL INDEX KEY: 0001398659 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MANAGEMENT CONSULTING SERVICES [8742] IRS NUMBER: 980533350 STATE OF INCORPORATION: D0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: FWP SEC ACT: 1934 Act SEC FILE NUMBER: 333-230982 FILM NUMBER: 21765709 BUSINESS ADDRESS: STREET 1: CANON'S COURT STREET 2: 22 VICTORIA STREET CITY: HAMILTON STATE: D0 ZIP: HM 12 BUSINESS PHONE: 4412952244 MAIL ADDRESS: STREET 1: CANON'S COURT STREET 2: 22 VICTORIA STREET CITY: HAMILTON STATE: D0 ZIP: HM 12 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Genpact Luxembourg S.a.r.l. CENTRAL INDEX KEY: 0001739032 IRS NUMBER: 980550714 STATE OF INCORPORATION: N4 FILING VALUES: FORM TYPE: FWP BUSINESS ADDRESS: STREET 1: 12F, RUE GUILLAUME KROLL CITY: LUXEMBOURG STATE: N4 ZIP: L-1882 BUSINESS PHONE: 352 26 987 686 MAIL ADDRESS: STREET 1: 12F, RUE GUILLAUME KROLL CITY: LUXEMBOURG STATE: N4 ZIP: L-1882 FWP 1 d166048dfwp.htm FWP FWP

Issuer Free Writing Prospectus

Filed Pursuant to Rule 433

Related to the Preliminary Prospectus Supplement dated March 23, 2021

Registration Number 333-230982

GENPACT LUXEMBOURG S.À R.L.

GENPACT USA, INC.

GENPACT LIMITED

$350,000,000 1.750% Senior Notes due 2026

Pricing Term Sheet

March 23, 2021

The information in this pricing term sheet supplements the Issuers’ preliminary prospectus supplement, dated March 23, 2021 (the “Preliminary Prospectus Supplement”) and supersedes the information in the Preliminary Prospectus Supplement to the extent inconsistent with the information in the Preliminary Prospectus Supplement. This pricing term sheet is qualified in its entirety by reference to the Preliminary Prospectus Supplement. Terms used herein but not defined herein shall have the respective meanings as set forth in the Preliminary Prospectus Supplement.

 

Issuers:   

Genpact Luxembourg S.à r.l.

Genpact USA, Inc.

Guarantor:    Genpact Limited
Expected Ratings (Moody’s / S&P)*:    Baa3 / BBB-
Security Title:    1.750% Senior Notes due 2026
Offering Format:    SEC registered
Pricing Date:    March 23, 2021
Settlement Date**:    March 26, 2021 (T+3)
Maturity Date:    April 10, 2026
Interest Payment Dates:    April 10 and October 10, commencing October 10, 2021
Principal Amount:    $350,000,000
Benchmark Treasury:    UST 0.500% due February 28, 2026
Benchmark Treasury Price / Yield:    98-13+ / 0.827%
Spread to Benchmark Treasury:    +95 bps
Yield to Maturity:    1.777%
Coupon:    1.750%

Public Offering Price:    99.870% of the principal amount, plus accrued interest, if any, from March 26, 2021
Optional Redemption Provisions:   

Make-Whole Call:

    Prior to March 10, 2026, T+15 bps

Par Call:

    On or after March 10, 2026
CUSIP / ISIN:    37190A AA7 / US37190AAA79
Joint Book-Running Managers:   

Citigroup Global Markets Inc.

Morgan Stanley & Co. LLC

Wells Fargo Securities, LLC

BofA Securities, Inc.

Credit Agricole Securities (USA) Inc.

J.P. Morgan Securities LLC

TD Securities (USA) LLC

 

*

Note: A securities rating is not a recommendation to buy, sell or hold securities and may be subject to revision or withdrawal at any time.

 

**

Pursuant to Rule 15c6-1 under the Securities Exchange Act of 1934, as amended, trades in the secondary market generally are required to settle in two business days, unless the parties to any such trade expressly agree otherwise. Accordingly, purchasers who wish to trade the notes prior to the delivery date may be required to specify an alternate settlement cycle at the time of trade to prevent a failed settlement. Investors who wish to trade the notes prior to the delivery date should consult their own advisors.

The Issuers have filed a registration statement, including a prospectus and a preliminary prospectus supplement, with the Securities and Exchange Commission (the “SEC”) for the offering to which this communication relates. Before you invest, you should read the prospectus and the preliminary prospectus supplement in that registration statement and other documents the Issuers have filed with the SEC for more complete information about the Issuers and this offering. You may get these documents for free by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, the Issuers, any underwriter or any dealer participating in the offering will arrange to send you the prospectus and the preliminary prospectus supplement (or, if available, the prospectus supplement) if you request it by calling Citigroup Global Markets Inc. toll-free at 1-800-831-9146; Morgan Stanley & Co. LLC toll-free at 1-866-718-1649; or Wells Fargo Securities, LLC toll-free at 1-800 645-3751.

ANY DISCLAIMERS OR OTHER NOTICES THAT MAY APPEAR BELOW ARE NOT APPLICABLE TO THIS COMMUNICATION AND SHOULD BE DISREGARDED. SUCH DISCLAIMERS OR OTHER NOTICES WERE AUTOMATICALLY GENERATED AS A RESULT OF THIS COMMUNICATION BEING SENT VIA BLOOMBERG OR ANOTHER EMAIL SYSTEM.